Key result
Peripartum cardiomyopathy mimics other conditions, delaying diagnosis until echocardiography shows severe LVEF reduction to ~30%.
Why the study?
Peripartum cardiomyopathy is a rare and potentially fatal cause of heart failure that is easily overlooked due to symptom overlap with other peripartum conditions.
Case Report (n=3)
No
Peripartum cardiomyopathy is frequently masked by mimicking conditions, underscoring the importance of maintaining an active differential and utilizing early natriuretic peptide testing and echocardiography in peripartum women with unexplained dyspnea.
May aid earlier recognition of peripartum cardiomyopathy; leaves open need for prospective validation before practice change.
Peripartum cardiomyopathy is a rare, potentially fatal, and easily overlooked cause of heart failure in the peripartum period, because its presenting symptoms mimic pneumonia, pulmonary embolism, anaemia, or the normal physiological burden of pregnancy. To describe the diagnostic challenges encountered in three consecutive women with definite or probable peripartum cardiomyopathy at a tertiary referral centre and to draw out practical lessons for earlier recognition in routine clinical practice. We retrospectively reviewed three consecutive women evaluated for definite or probable peripartum cardiomyopathy at a single tertiary internal medicine department, characterising presentation, diagnostic work-up, treatment, and follow-up from hospital records. All three women had at least one established or previously reported factor associated with PPCM, including preeclampsia, multiparity, twin pregnancy, or anaemia; all were also active smokers. All three initially presented with, or were being treated for, conditions that either mimicked or coexisted with PPCM (suspected pulmonary embolism, community-acquired pneumonia, or severe iron-deficiency anaemia) before echocardiography demonstrated left ventricular systolic dysfunction with an LVEF of 25–35%. Patient 1 achieved normalisation of LVEF within one month, whereas Patient 2 had persistent LV systolic dysfunction. Patient 3, classified as having probable PPCM in the presence of a previously unrecognised atrial septal defect, showed partial recovery to 45–48% by three months. Peripartum cardiomyopathy should remain an active differential in any peripartum woman with unexplained dyspnoea, even when an alternative diagnosis appears to explain the presentation. Early natriuretic peptide testing and echocardiography, cautious application of diagnostic criteria in the presence of confounding comorbidity, and attention to treatment adherence and follow-up are important for timely recognition and long-term management.
No takes yet. Share an insight, caveat, or question.
Tokarčíková et al. (2026) conducted a case report in Peripartum cardiomyopathy (n=3). Peripartum cardiomyopathy was evaluated on Left ventricular ejection fraction and clinical recovery. Peripartum cardiomyopathy presented with mimicking conditions in all three women, delaying diagnosis until echocardiography revealed left ventricular ejection fractions of 25-35%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: